Morgan Stanley’s MorphoSys AG American Depositary Shares MOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-354
| Closed | -$6.44K | – | 8119 |
|
|
2024
Q2 | $6.44K | Sell |
354
-334,078
| -100% | -$6.07M | ﹤0.01% | 6790 |
|
|
2024
Q1 | $6.07M | Sell |
334,432
-203,656
| -38% | -$3.01M | ﹤0.01% | 3765 |
|
|
2023
Q4 | $5.33M | Buy |
538,088
+400,603
| +291% | +$2.94M | ﹤0.01% | 4343 |
|
|
2023
Q3 | $924K | Sell |
137,485
-5,542
| -4% | -$42.7K | ﹤0.01% | 4845 |
|
|
2023
Q2 | $1.07M | Sell |
143,027
-2,501
| -2% | -$15.2K | ﹤0.01% | 4788 |
|
|
2023
Q1 | $576K | Sell |
145,528
-3,425
| -2% | -$15.1K | ﹤0.01% | 5173 |
|
|
2022
Q4 | $533K | Sell |
148,953
-11,599
| -7% | -$51.9K | ﹤0.01% | 5212 |
|
|
2022
Q3 | $808K | Sell |
160,552
-15,100
| -9% | -$78K | ﹤0.01% | 5008 |
|
|
2022
Q2 | $849K | Buy |
175,652
+16,300
| +10% | +$90K | ﹤0.01% | 5115 |
|
|
2022
Q1 | $1.08M | Sell |
159,352
-30,645
| -16% | -$227K | ﹤0.01% | 4937 |
|
|
2021
Q4 | $1.79M | Buy |
189,997
+37,376
| +24% | +$397K | ﹤0.01% | 4669 |
|
|
2021
Q3 | $1.79M | Sell |
152,621
-5,386
| -3% | -$78K | ﹤0.01% | 4655 |
|
|
2021
Q2 | $3.04M | Sell |
158,007
-3,604
| -2% | -$77.1K | ﹤0.01% | 4278 |
|
|
2021
Q1 | $3.52M | Sell |
161,611
-44,831
| -22% | -$1.2M | ﹤0.01% | 3772 |
|
|
2020
Q4 | $5.85M | Sell |
206,442
-25,134
| -11% | -$689K | ﹤0.01% | 3087 |
|
|
2020
Q3 | $7.27M | Sell |
231,576
-251,780
| -52% | -$8.16M | ﹤0.01% | 2339 |
|
|
2020
Q2 | $15.3M | Buy |
483,356
+57,885
| +14% | +$1.69M | ﹤0.01% | 1612 |
|
|
2020
Q1 | $10.5M | Buy |
425,471
+66,716
| +19% | +$1.96M | ﹤0.01% | 1728 |
|
|
2019
Q4 | $12.8M | Buy |
358,755
+309,876
| +634% | +$9.26M | ﹤0.01% | 2128 |
|
|
2019
Q3 | $1.34M | Buy |
48,879
+6,287
| +15% | +$180K | ﹤0.01% | 4109 |
|
|
2019
Q2 | $1.03M | Buy |
42,592
+41,134
| +2,821% | +$1.02M | ﹤0.01% | 4205 |
|
|
2019
Q1 | $33K | Sell |
1,458
-63
| -4% | -$1.65K | ﹤0.01% | 5841 |
|
|
2018
Q4 | $38K | Sell |
1,521
-15,178
| -91% | -$398K | ﹤0.01% | 5834 |
|
|
2018
Q3 | $446K | Sell |
16,699
-13,232
| -44% | -$398K | ﹤0.01% | 5062 |
|
|
2018
Q2 | $909K | Buy |
+29,931
| New | +$822K | ﹤0.01% | 4687 |
|
Other funds holding MOR
HWAM
GI
BTI
Morgan Stanley's MOR Position: Q3 2024 in Review
Morgan Stanley sold out of MorphoSys AG American Depositary Shares (MOR) in Q3 2024, closing a stake of 354 shares — an estimated $6.44K sold.
Morgan Stanley first reported a position in MOR in Q2 2018 and held it in 25 quarters. The position peaked at $15.3M in Q2 2020. 9 funds tracked by Wall St. Rank hold MOR as of Q3 2024.
- Morgan Stanley reported no remaining MorphoSys AG American Depositary Shares position as of Q3 2024 after selling out during the quarter.
- Morgan Stanley sold 354 MorphoSys AG American Depositary Shares shares in Q3 2024, an estimated $6.44K.
- Morgan Stanley first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 25 quarters.
- Morgan Stanley's MorphoSys AG American Depositary Shares position peaked at $15.3M in Q2 2020.
- 9 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2024.
Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.